SavedAdd your journal

Journals / Abant Tıp Dergisi / 2013 / Cilt: 2 - Sayı: 1

N- terminal pro B-tip natriüretik peptit ve vücut kitle indeksi arasındaki ilişki

Relationship between N -terminal pro B-type natriuretic peptide and body mass index

Banu ÖZTÜRK
Türker TAŞLIYURT
Faruk KUTLUTÜRK
Berna YELKEN
Şafak ŞAHİN
Pages
32–35
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Elevated NT-pro BNP in obese patients may be explained by changes in the heart structure that hypertension leads.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective : N -terminal pr o B -type natriuretic pe ptide (NT-pro BNP) is secreted from the cardiac ventric les in response to volume expansion.
📊
Key Findings & Data:Method: Forty -two obese patients (37 women, 5 men; body mass index ≥ 30) and thirty -five normal body mass index individuals (27 women, 8 men; body mass index ≤ 25) were analyzed regarding NT-pro BNP.Results: The serum levels of NT-pro BNP was signifi- cantly higher in obese patients than normal body mass index individuals (p=0,027).
💡
Conclusion & Impact:Elevated NT-pro BNP in obese patients may be explained by changes in the heart structure that hypertension leads.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective : N -terminal pr o B -type natriuretic pe ptide (NT-pro BNP) is secreted from the cardiac ventric les in response to volume expansion. The effect of obesity on natriuretic peptide has yet to be fully elucidated. We aimed to compare the NT-pro BNP levels in obese and in healthy individuals with normal body mass index. Method: Forty -two obese patients (37 women, 5 men; body mass index ≥ 30) and thirty -five normal body mass index individuals (27 women, 8 men; body mass index ≤ 25) were analyzed regarding NT-pro BNP.Results: The serum levels of NT-pro BNP was signifi- cantly higher in obese patients than normal body mass index individuals (p=0,027). No correlation was found between body mass index and NT-pro BNP. Statistica lly significant difference was found between systolic and diastolic blood pressures in both groups (p<0.001 and p<0.001; respectively) Conclusion: We found that NT-pro BNP was higher in obese than control groups. Elevated NT-pro BNP in obese patients may be explained by changes in the heart structure that hypertension leads.

Özet

Amaç: N -terminal pro B -tip natriüretik peptid (NT-proBNP) hacim genişlemesinde yanıt olarak kardiyak ventriküllerden salgılanır. Natriüretik peptid üzerine obez itenin etkisi henüz tam olarak aydınlatılmış değildir. Buçalışmada normal kilolu ve obez bireylerde NT-proBNP düzeylerinin karşılaştırılması amaçlandı.Yöntem: Çalışmaya kırkiki obez hasta (37 kadın, 5erkek; vücut kitle indeksi ≥ 30) ve normal kilolu otu zbeş kişi (27 kadın, 8 erkek; vücut kitle indeksi ≤ 25)kontrol grubu olarak alındı. Hasta ve kontrol grubununNT-pro BNP düzeyleri karşılaştırıldı.Bulgular: NT-pro BNP düzeyleri obez hastalarda kontrol grubuna göre anlamlı olarak yüksek bulundu(p=0.027). Vücut kitle indeksi ile NT-pro BNP arasındakorelasyon yoktu. Obez hastalarda sistolik ve diyastolikkan basınçları istatistiksel olarak yüksekti (sırasıyla; p<0.001 ve p <0.001). Sonuç: Obezlerde kontrol grubuna göre NT-pro BNPdüzeyleri daha yüksek olduğu bulundu. Obez hastala rdaki yüksek NT-pro BNP hipertansiyonun yol açtığıkalp yapısındaki değişiklikler ile açıklanabilir.

🔖

Cite This Article

ÖZTÜRK, B., TAŞLIYURT, T., KUTLUTÜRK, F., YELKEN, B., ŞAHİN, Ş. (2022). N- terminal pro B-tip natriüretik peptit ve vücut kitle indeksi arasındaki ilişki. Abant Tıp Dergisi, Cilt: 2 - Sayı: 1, 32–35. https://ajindex.com/articles/427235

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Kenchaiah S, Evans JC, Levy Wilson PW, Benja min EJ, Larson MG, Kannel WB, Vassan RS, Obesity and the risk of heart failure. N Engl J Med. 2002
  2. 13 2. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geom etry JAMA 1991
  3. 6 3. Reisin E, Messerli FH. Obesity -related hyperte nsion: mechanisms, cardiovascular risks, and h e redity. Curr Opin Nephrol Hyperten 1995
  4. 71 4. Rocchini AP, Moorehead CP, DeRemer S, Bondie D. Pathogenesis of weight related changes in blood pressure in dogs. Hypertension 1989
  5. 8 5. Rocchini AP. Insulin resistance and blood pre s sure regulation in obese and non -obese subjects. Hype rtension 1991
  6. 42 6. Rocchini AP, Key S, Bondie D. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescent. N Engl J Med 1989
  7. 5 7. Levin ER, Gardner DG, Samson WK. Natriuretic pe ptids. N Engl J Med 1998
  8. 28 8. Schirmer H, Omland T. Circulating N -terminal pro atrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general popul ation. The Tromso Study. Eur Heart J. 1999
  9. 63 9. Lerman A, Gibbons RJ, Rodeheffer RJ, McKinley LJ, Heublein DM, Burnett JC Jr. Circulating N -terminal atrial natriuretic peptide as a marker for symptom less left-ventricular dysfunction. Lancet 1993
  10. 9 10. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, Tunstall -Pedoe H, McMurray JJ, Dargie HJ. Biochemical detection of left ventricular systol ic dysfunction. Lancet 1998
  11. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thom pson SG, Poole -Wilson PA, Sutton GC. Value of natriuretic peptides in assessment of patients with possible new heart failure in pri mary care. Lancet 1997
  12. 53 12. Messerli FH, Ventura HO, Reisin E, Dreslinski GR, Dunn FG, MacPhee AA, Frohlich ED. Borderline hype rtension and obesity: two prehypertensivestate with elevated cardiac output. Ci rculation. 1982
  13. 60 13. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, Sutherland P, Omland T, Vasan RS. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002
  14. 8 14. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS. Impact of obesity o plasma n atriuretic peptide levels. Circulation 2004
  15. 600 15. Licata G, Volpe M, Scaglione R, Rubattu S. Saltregulating hormones in young normotensive obes